A pill version of the popular GLP-1 weight-loss drug Wegovy has been greenlit for use in the U.S. Here’s what that means for ...

The Wegovy pill is FDA-approved to reduce excess body weight and maintain weight reduction long-term in adults who have ...

Yesterday, the Food and Drug Administration (FDA) approved Novo Nordisk‘s (NYSE:NVO) Wegovy weight-loss pill, the first of its kind. This once-daily tablet uses the same active ingredient — ...

After ushering in a new era of obesity treatment with its GLP-1 medicine Wegovy earlier in the decade, Novo Nordisk is making ...

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily ...

The US food and drug administration (FDA) has approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, ...

The approval marks the first time an oral drug has been authorised specifically to treat obesity, offering an alternative to ...

The approval gives Novo Nordisk a head start over chief rival Eli Lilly, which is racing to launch its own obesity pill.

The FDA has approved the oral version of Novo Nordisk’s injectable weight loss drug Wegovy, making it the first GLP-1 pill to ...

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

The FDA has yet to approve the best new weight-loss drug. But some people are buying it from shadowy markets online.

LONDON, Dec 23 () - Novo Nordisk's newly approved weight-loss pill version of Wegovy will be a test case for the fast-growing ...